
Sign up to save your podcasts
Or


WuXi is back on the Pentagon’s blacklist. The United States Treasury might restrict investments in Chinese biotech. Despite wave after wave of big pharma announcements around partnerships with China, the protectionist voices are taking up more airtime. Where are the winds blowing, and what material impact could this all have?
Stay ahead of biopharma. Get the Main Edition in your inbox M-F at 11:30 AM ET. Sign up: https://shorturl.at/OBB3D
By Endpoints News5
33 ratings
WuXi is back on the Pentagon’s blacklist. The United States Treasury might restrict investments in Chinese biotech. Despite wave after wave of big pharma announcements around partnerships with China, the protectionist voices are taking up more airtime. Where are the winds blowing, and what material impact could this all have?
Stay ahead of biopharma. Get the Main Edition in your inbox M-F at 11:30 AM ET. Sign up: https://shorturl.at/OBB3D

32,100 Listeners

30,666 Listeners

26,197 Listeners

1,967 Listeners

766 Listeners

111,948 Listeners

56,508 Listeners

337 Listeners

1,038 Listeners

6,089 Listeners

3,032 Listeners

10,182 Listeners

34 Listeners

143 Listeners

13 Listeners